Menopause and Bladder Leaks: Understanding the Link

If you've noticed some leakage when you sneeze, laugh or exercise or a sudden, hard-to-ignore urge to urinate since your periods stopped, you're far from alone. This is one of the most common and least talked about, symptoms that women can experience with menopause. It certainly doesn’t mean it is ‘normal’ – however, yes it is very common. Stress incontinence alone affects roughly a quarter to over half of women past age 60, and pelvic floor issues more broadly show up in about half of postmenopausal women (Ptak et al., 2025). Understanding why it happens is the first step toward managing it well.

Why menopause affects the bladder

The bladder, urethra, vagina and pelvic floor all develop from the same embryonic tissue, which is part of why they're so responsive to hormonal shifts (Robinson et al., 2020). When oestrogen shifts at menopause, several changes happen at once:

• Connective tissue loses some of its support. Oestrogen helps maintain collagen, the tissue that keeps the urethra properly supported. As oestrogen drops, that support can loosen, affecting how well the urethra stays closed under pressure (Robinson et al., 2020).

• Blood flow to the urethra decreases. The blood vessels around the urethra contribute meaningfully to keeping it sealed between voids and estrogen helps maintain them (Alsulihem et al., ClinicalTrials.gov protocol).

• Pelvic floor muscle quality changes. Postmenopausal women often experience a decline in muscle fiber quality, weakening contraction strength. Interestingly, some studies also find the muscles become stiffer at rest, pointing to genuine structural change rather than simple weakness that exercise alone can fully reverse.

• The bladder becomes more reactive. Oestrogen influences bladder muscle activity, so its decline can increase urgency and lower the threshold at which the bladder signals "time to go”.

  
  

Collectively, these changes fall under the term genitourinary syndrome of menopause (GSM) as discussed in previous editions, which refers to the vaginal, vulvar and urinary symptoms associated with changing oestrogen. Estimates of how many postmenopausal women are affected vary widely, from about a quarter to the majority, depending on the study population.

Two main types of incontinence

• Stress urinary incontinence: leakage triggered by coughing, sneezing, laughing or physical activity that puts pressure on the bladder.

• Urgency urinary incontinence: a sudden, strong need to urinate, sometimes with little warning.

Many women experience a combination of both, known as mixed urinary incontinence.

An often-overlooked factor: anxiety and the bladder

This connection deserves more attention than it usually gets, and the relationship runs in both directions. Anxiety doesn't just make incontinence more distressing to live with - there's real evidence it can contribute to the symptoms themselves. A large longitudinal study of women over 40 found that anxiety and depression predicted the later onset of urge incontinence, while incontinence also predicted new cases of anxiety and depression (Perry et al., cited in PubMed 16870056).

There's a plausible physiological explanation, too. Anxiety activates the sympathetic nervous system, which can affect the nerves supplying the bladder and alter the resting tension and responsiveness of the pelvic floor muscles. Researchers have described this as a "brain-gut-bladder axis," where chronic stress and anxiety can directly influence bladder sensitivity and overactive bladder symptoms, not merely a person's perception of them (Smith et al., 2024, Neurourology and Urodynamics).

Menopause can bring a rise in anxiety at the same time these physical bladder changes are occurring, which can create a self-reinforcing cycle - bladder symptoms increase stress, and stress worsens bladder symptoms.

Recognising this cycle is genuinely useful, because it means addressing anxiety is a legitimate part of managing incontinence, not a secondary concern.

Worth knowing about hormone therapy

This distinction often gets lost. Vaginal (local) oestrogen, applied at a low dose directly to the vaginal tissue, reliably improves GSM symptoms including urgency and urge incontinence, with minimal absorption into the bloodstream.

Systemic estrogen - oral or transdermal therapy that circulates throughout the body - tells a different story. Large trials, including data from the Women's Health Initiative, found it does not improve incontinence and may actually worsen stress incontinence, particularly when combined with a progestogen. The 2022 NAMS position statement is explicit on this point: systemic hormone therapy does not improve urinary incontinence and may increase the risk of stress incontinence, whereas low-dose vaginal estrogen can benefit urgency symptoms and reduce recurrent UTIs.

This is worth raising with your doctor if hormone therapy is under consideration.

What can help…

1. Pelvic floor physiotherapy. A supervised, progressive pelvic floor training program - ideally with a pelvic health physiotherapist and biofeedback - is the best-supported first step and benefits both stress and urgency incontinence.

2. Bladder training and lifestyle adjustments. Timed voiding, reducing caffeine intake, and maintaining a healthy weight are low-risk, evidence-supported first-line measures.

3. Addressing anxiety directly. Given the documented bidirectional link, therapy, mindfulness-based and body connection approaches, or simply acknowledging stress as a genuine contributor can meaningfully support physical symptom management.

4. Low-dose vaginal estrogen for persistent urgency symptoms once conservative measures haven't fully resolved them.

5. Combined approaches. Emerging research is testing pelvic floor training alongside vaginal estrogen therapy, since the two address different underlying mechanisms.

To takeaway...

Urinary incontinence after menopause isn't a personal failing or simply an inevitable part of aging - it's a specific, explainable result of hormonal changes affecting tissue, muscle and nerve function, with anxiety and stress genuinely woven into the picture as well. It's also highly treatable, particularly with adjustments in lifestyle. A conversation with a doctor or pelvic health physiotherapist is a strong place to start.

---

References

1. Ptak, M., et al. (2025). Training Interventions Used in Postmenopausal Women to Improve Pelvic Floor Muscle Function Related to Urinary Continence—A Systematic Review. PMC12251402.

2. Robinson, D., Bianchi-Ferraro, A. M. H. C., et al. (2020). Effectiveness of hormones in postmenopausal pelvic floor dysfunction—International Urogynecological Association research and development—committee opinion. International Urogynecology Journal. PMC7363722.

3. EMAS Clinical Guide (2020). Management of urinary incontinence in postmenopausal women: An EMAS clinical guide. Maturitas, ScienceDirect S0378512220303674.

4. The NAMS 2020 GSM Position Statement Editorial Panel. (2020). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause, 27(9), 976–992.

5. The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause.

6. ClinicalTrials.gov. (2025). Telerehabilitation Versus Supervised Pelvic Floor Muscle Training in Urinary Incontinence, Protocol NCT07151170.

7. ClinicalTrials.gov. Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women, Protocol NCT06508944.

8. ClinicalTrials.gov. The Effectiveness of Combined Pelvic Floor Muscle Training and Vaginal Oestrogen Therapy in Postmenopausal Women With Stress Urinary Incontinence, NCT07186985.

9. Perry, S., McGrother, C. W., Turner, K., & Leicestershire MRC Incontinence Study Group. An investigation of the relationship between anxiety and depression and urge incontinence in women: development of a psychological model. PubMed 16870056.

10. Association between Menopausal Transition Stages and Developing Urinary Incontinence. PMC3120214.

11. Smith, A. L., Berry, A., Brubaker, L., et al. (2024). The brain, gut, and bladder health nexus: A conceptual model linking stress and mental health disorders to overactive bladder in women. Neurourology and Urodynamics, 43(2), 424–436.

    
    

This article is for general educational purposes and is not a substitute for individualised medical advice. Women experiencing incontinence or bladder-related anxiety should speak with a gynaecologist, urogynaecologist, or pelvic health physiotherapist for personalised evaluation and treatment.